Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Biocept Inc

(NASDAQ: BIOC)
Add to Portfolio
+0.03 (+3.53%)
as of Sep 20, 2019

Last 0.88
Change +0.03 (+3.53%)
Open 0.85
Prev. Close 0.85
Today's Range
0.85
0.88
52wk Range
0.66
3.72
Volume 235,400
Avg Volume 298,740
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
BIOC +3.53% -13.30% -73.52%
DJIA -0.59% -0.56% +1.04%
S&P 500 -0.49% -0.26% +2.09%

Key Statistics

Annual EPS -4.84
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 19,710
Weighted Alpha -73.56
Standard Deviation +1.26
Profit Margin 3.63%
Beta 2.03

Growth Rates

YTD +2.83%
1-Year -69.92%
3-Year -98.33%
5-Year -99.65%

Opinion

Sell Hold Buy

Recent Headlines

Biocept to Present at Two Investment Conferences in

PR Newswire via COMTEX - Tue Sep 03, 08:05AM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that man(full story)
BIOC: 0.88 (+0.03)

High Sensitivity of Biocept's Target Selector(TM)

PR Newswire via COMTEX - Thu Aug 22, 08:05AM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that cli(full story)
BIOC: 0.88 (+0.03)

Biocept Receives Three Additional Patents Covering its

PR Newswire via COMTEX - Tue Aug 13, 08:05AM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it (full story)
BIOC: 0.88 (+0.03)

Biocept Reports Second Quarter 2019 Financial Results

PR Newswire via COMTEX - Mon Aug 12, 04:05PM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports financial results for the(full story)
BIOC: 0.88 (+0.03)

Biocept, Inc. to Host Earnings Call

ACCESSWIRE via COMTEX - Mon Aug 12, 02:37PM EDT
NEW YORK, NY / ACCESSWIRE / August 12, 2019 / Biocept, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 12, 2019 at 4:30 PM Eastern Time.(full story)
BIOC: 0.88 (+0.03)